Reply to "diminishing role of platinum-sensitivity status in patients with small cell lung cancer"

Affiliations

¹ University of California Davis, Comprehensive Cancer Center, Sacramento, CA. Electronic address: primo.lara@ucdmc.ucdavis.edu.
² University of California Davis, Comprehensive Cancer Center, Sacramento, CA.
³ SWOG Statistical Center, Seattle, WA.

Free article

Comment

Primo N Lara Jr et al. J Thorac Oncol. 2015 May.

Free article

. 2015 May;10(5):e36.

doi: 10.1097/JTO.0000000000000515.

¹ University of California Davis, Comprehensive Cancer Center, Sacramento, CA. Electronic address: primo.lara@ucdmc.ucdavis.edu.
² University of California Davis, Comprehensive Cancer Center, Sacramento, CA.
³ SWOG Statistical Center, Seattle, WA.

No abstract available

Comment on

Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials.
Lara PN Jr, Moon J, Redman MW, Semrad TJ, Kelly K, Allen JW, Gitlitz BJ, Mack PC, Gandara DR. Lara PN Jr, et al. J Thorac Oncol. 2015 Jan;10(1):110-5. doi: 10.1097/JTO.0000000000000385. J Thorac Oncol. 2015. PMID: 25490004 Free PMC article. Clinical Trial.
Relevance of platinum sensitivity in patients with relapsed or refractory small-cell lung cancer.
Kim YH, Mishima M. Kim YH, et al. J Thorac Oncol. 2015 May;10(5):e35. doi: 10.1097/JTO.0000000000000513. J Thorac Oncol. 2015. PMID: 25898966 No abstract available.
Second-line Treatment of Small Cell Lung Cancer: Is Platinum Sensitivity a Relevant Prognostic Factor?
Tiseo M, Boni L, Ardizzoni A. Tiseo M, et al. J Thorac Oncol. 2015 May;10(5):e35-e36. doi: 10.1097/JTO.0000000000000514. J Thorac Oncol. 2015. PMID: 25898967 No abstract available.